Get your free ETF data sample from our comprehensive offerings. Start your free trial

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

ARXK

ARK Innovation UCITS ETF

The ARXK Exchange Traded Fund (ETF) is provided by ARK Invest Europe. This fund is actively managed; it does not track an index. The dividend policy is capitalization.

Advertisement

Advertisement

€8.01
+€0.11 (+1.42%) today
7:32 AM 09/03/26 Open
1D price range
€7.99€8.02
52W price range
€5.90€8.36
YTD Perf.
+14.61%
YTD Flows
Annualized volatility
Fund AuM
€263M
Share class AuM
€263M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
IE000GA3D489
TER
0.75%
Inception date
4/12/2024
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Sep 1, 2026
-20%-10%0%10%20%JANMARMAYJULSEP
Flows
Join for free to unlock
Data as of 07/31/26
Healthcare
30.65%
Finance
23.96%
Technology
19.80%
Consumer Cyclicals
8.89%
Industrials
4.27%
Consumer Non-Cyclicals
2.59%
Business Services
2.51%
Unavailable
6.64%
Other
0.71%
Latest ARXK news

No content available for this fund

FAQ about ARXK

ARXK is a Active ETF. This ETF provides exposure to Other Equities.
ARXK carries a total expense ratio (TER) of 0.75%, indicating the annual cost for holding the fund.
ARXK was introduced to the market on April 12, 2024. It trades on Ireland, among other exchanges
ARK Innovation UCITS ETF, ARXK, is provided by ARK Invest Europe. Learn more about ARK Invest Europe here.
ARXK oversees €263M in assets as of September 1, 2026.
ARXK follows a capitalizing, meaning it reinvests income within the fund.
As of July 31, 2026, ARXK has significant geographic allocations in USA, Canada and Switzerland.
As of July 31, 2026, ARXK focuses largely on Healthcare, Finance and Technology.
As of July 31, 2026, ARXK holds 44 positions in its portfolio, with 64.67% of assets concentrated in its top 15 holdings.
As of July 31, 2026, ARXK top three holdings include Tesla, Inc., Robinhood Markets, Inc. and CRISPR Therapeutics AG.
The base currency of ARXK is USD.
Data as of 07/31/26
Tesla, Inc.
8.89%
Robinhood Markets, Inc.
5.33%
CRISPR Therapeutics AG
5.02%
US84615Q1031
4.96%
Advanced Micro Devices, Inc.
4.60%
Coinbase Global, Inc.
4.42%
Shopify, Inc.
4.33%
10X Genomics, Inc.
4.27%
Tempus AI, Inc.
4.06%
Circle Internet Group, Inc.
3.60%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight